APO RESEARCH · REPORT
Florfenicol
Florfenicol is a monofluorinated derivative of thiamphenicol. Florfenicol is a chloramphenicol broad-spectrum antibiotic that can effectively inhibit bacteria. Its antibacterial activity is stronger than that of chloramphenicol and thiamphenicol. Florfenicol overcomes the problems that chloramphenicol is prone to drug resistance and aplastic anemia, and has the characteristics of wide antibacterial spectrum, good oral absorption, wide distribution in the body, high bioavailability, and safe application.
Product & engineering
Understand the product.
Florfenicol is a monofluorinated derivative of thiamphenicol. Florfenicol is a chloramphenicol broad-spectrum antibiotic that can effectively inhibit bacteria. Its antibacterial activity is stronger than that of chloramphenicol and thiamphenicol. Florfenicol overcomes the problems that chloramphenicol is prone to drug resistance and aplastic anemia, and has the characteristics of wide antibacterial spectrum, good oral absorption, wide distribution in the body, high bioavailability, and safe application.
Selected research
Industry Research
Florfenicol Industry Research Report 2026
Market perspective
Florfenicol is a monofluorinated derivative of thiamphenicol. Florfenicol is a chloramphenicol broad-spectrum antibiotic that can effectively inhibit bacteria. Its antibacterial activity is stronger than that of chloramphenicol and thiamphenicol. Florfenicol overcomes the problems that chloramphenicol is prone to drug resistance and aplastic anemia, and has the characteristics of wide antibacterial spectrum, good oral absorption, wide distribution in the body, high bioavailability, and safe application.
The industry's leading producers are Merck Animal Health, Hisoar Pharmaceutical and Lianhuan Pharmaceutical, with revenues of 16.19%, 13.03% and 12.25%, respectively, in 2019.
Report Scope
Read the full market overview
This report quantifies the global Florfenicol market in terms of revenue (US$ million) and, where applicable, sales volume (Ton), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Ton) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Florfenicol Market by Company
Merck Animal Health
Hisoar Pharmaceutical
Lianhuan Pharmaceutical
Hansyn Pharma
Zhejiang Kangmu Pharmaceutical
CAHIC
ShanDong Guobang Pharmaceutical
Longxiang Pharmaceutical
Masteam Bio-tech
Hankuo
Runkang Pharmaceutical
Jiangxi Dongxu
Interchemie
Temad
Tecoland
Florfenicol Segment by Type
Purity ≥ 98%
Purity ≥ 99.5%
Florfenicol Segment by Application
Livestock
Poultry
Aquaculture
Florfenicol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Florfenicol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Florfenicol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Florfenicol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Florfenicol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Florfenicol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Florfenicol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥ 98%
- Purity ≥ 99.5%
Applications
- Livestock
- Poultry
- Aquaculture
Companies covered
- Merck Animal Health
- Hisoar Pharmaceutical
- Lianhuan Pharmaceutical
- Hansyn Pharma
- Zhejiang Kangmu Pharmaceutical
- CAHIC
- ShanDong Guobang Pharmaceutical
- Longxiang Pharmaceutical
- Masteam Bio-tech
- Hankuo
- Runkang Pharmaceutical
- Jiangxi Dongxu
- Interchemie
- Temad
- Tecoland
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Florfenicol Market Size (2021-2032)
- 2.2.2 Global Florfenicol Sales (2021-2032)
- 2.2.3 Global Florfenicol Market Average Price (2021-2032)
- 2.3 Florfenicol by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity ≥ 98%
- 2.3.3 Purity ≥ 99.5%
- 2.4 Florfenicol by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Livestock
- 2.4.3 Poultry
- 2.4.4 Aquaculture
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Florfenicol Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Florfenicol Sales (Ton) of Manufacturers (2021-2026)
- 3.3 Global Florfenicol Revenue of Manufacturers (2021-2026)
- 3.4 Global Florfenicol Average Price by Manufacturers (2021-2026)
- 3.5 Global Florfenicol Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Florfenicol, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Florfenicol, Product Type & Application
- 3.8 Global Manufacturers of Florfenicol, Established Date
- 3.9 Global Florfenicol Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck Animal Health
- 4.1.1 Merck Animal Health Company Information
- 4.1.2 Merck Animal Health Business Overview
- 4.1.3 Merck Animal Health Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck Animal Health Florfenicol Product Portfolio
- 4.1.5 Merck Animal Health Recent Developments
- 4.2 Hisoar Pharmaceutical
- 4.2.1 Hisoar Pharmaceutical Company Information
- 4.2.2 Hisoar Pharmaceutical Business Overview
- 4.2.3 Hisoar Pharmaceutical Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hisoar Pharmaceutical Florfenicol Product Portfolio
- 4.2.5 Hisoar Pharmaceutical Recent Developments
- 4.3 Lianhuan Pharmaceutical
- 4.3.1 Lianhuan Pharmaceutical Company Information
- 4.3.2 Lianhuan Pharmaceutical Business Overview
- 4.3.3 Lianhuan Pharmaceutical Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Lianhuan Pharmaceutical Florfenicol Product Portfolio
- 4.3.5 Lianhuan Pharmaceutical Recent Developments
- 4.4 Hansyn Pharma
- 4.4.1 Hansyn Pharma Company Information
- 4.4.2 Hansyn Pharma Business Overview
- 4.4.3 Hansyn Pharma Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hansyn Pharma Florfenicol Product Portfolio
- 4.4.5 Hansyn Pharma Recent Developments
- 4.5 Zhejiang Kangmu Pharmaceutical
- 4.5.1 Zhejiang Kangmu Pharmaceutical Company Information
- 4.5.2 Zhejiang Kangmu Pharmaceutical Business Overview
- 4.5.3 Zhejiang Kangmu Pharmaceutical Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zhejiang Kangmu Pharmaceutical Florfenicol Product Portfolio
- 4.5.5 Zhejiang Kangmu Pharmaceutical Recent Developments
- 4.6 CAHIC
- 4.6.1 CAHIC Company Information
- 4.6.2 CAHIC Business Overview
- 4.6.3 CAHIC Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 CAHIC Florfenicol Product Portfolio
- 4.6.5 CAHIC Recent Developments
- 4.7 ShanDong Guobang Pharmaceutical
- 4.7.1 ShanDong Guobang Pharmaceutical Company Information
- 4.7.2 ShanDong Guobang Pharmaceutical Business Overview
- 4.7.3 ShanDong Guobang Pharmaceutical Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ShanDong Guobang Pharmaceutical Florfenicol Product Portfolio
- 4.7.5 ShanDong Guobang Pharmaceutical Recent Developments
- 4.8 Longxiang Pharmaceutical
- 4.8.1 Longxiang Pharmaceutical Company Information
- 4.8.2 Longxiang Pharmaceutical Business Overview
- 4.8.3 Longxiang Pharmaceutical Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Longxiang Pharmaceutical Florfenicol Product Portfolio
- 4.8.5 Longxiang Pharmaceutical Recent Developments
- 4.9 Masteam Bio-tech
- 4.9.1 Masteam Bio-tech Company Information
- 4.9.2 Masteam Bio-tech Business Overview
- 4.9.3 Masteam Bio-tech Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Masteam Bio-tech Florfenicol Product Portfolio
- 4.9.5 Masteam Bio-tech Recent Developments
- 4.10 Hankuo
- 4.10.1 Hankuo Company Information
- 4.10.2 Hankuo Business Overview
- 4.10.3 Hankuo Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hankuo Florfenicol Product Portfolio
- 4.10.5 Hankuo Recent Developments
- 4.11 Runkang Pharmaceutical
- 4.11.1 Runkang Pharmaceutical Company Information
- 4.11.2 Runkang Pharmaceutical Business Overview
- 4.11.3 Runkang Pharmaceutical Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Runkang Pharmaceutical Florfenicol Product Portfolio
- 4.11.5 Runkang Pharmaceutical Recent Developments
- 4.12 Jiangxi Dongxu
- 4.12.1 Jiangxi Dongxu Company Information
- 4.12.2 Jiangxi Dongxu Business Overview
- 4.12.3 Jiangxi Dongxu Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Jiangxi Dongxu Florfenicol Product Portfolio
- 4.12.5 Jiangxi Dongxu Recent Developments
- 4.13 Interchemie
- 4.13.1 Interchemie Company Information
- 4.13.2 Interchemie Business Overview
- 4.13.3 Interchemie Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Interchemie Florfenicol Product Portfolio
- 4.13.5 Interchemie Recent Developments
- 4.14 Temad
- 4.14.1 Temad Company Information
- 4.14.2 Temad Business Overview
- 4.14.3 Temad Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Temad Florfenicol Product Portfolio
- 4.14.5 Temad Recent Developments
- 4.15 Tecoland
- 4.15.1 Tecoland Company Information
- 4.15.2 Tecoland Business Overview
- 4.15.3 Tecoland Florfenicol Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Tecoland Florfenicol Product Portfolio
- 4.15.5 Tecoland Recent Developments
5 Global Florfenicol Market Scenario by Region
- 5.1 Global Florfenicol Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Florfenicol Sales by Region: 2021-2032
- 5.2.1 Global Florfenicol Sales by Region: 2021-2026
- 5.2.2 Global Florfenicol Sales by Region: 2027-2032
- 5.3 Global Florfenicol Revenue by Region: 2021-2032
- 5.3.1 Global Florfenicol Revenue by Region: 2021-2026
- 5.3.2 Global Florfenicol Revenue by Region: 2027-2032
- 5.4 North America Florfenicol Market Facts & Figures by Country
- 5.4.1 North America Florfenicol Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Florfenicol Sales by Country (2021-2032)
- 5.4.3 North America Florfenicol Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Florfenicol Market Facts & Figures by Country
- 5.5.1 Europe Florfenicol Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Florfenicol Sales by Country (2021-2032)
- 5.5.3 Europe Florfenicol Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Florfenicol Market Facts & Figures by Country
- 5.6.1 Asia Pacific Florfenicol Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Florfenicol Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Florfenicol Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Florfenicol Market Facts & Figures by Country
- 5.7.1 South America Florfenicol Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Florfenicol Sales by Country (2021-2032)
- 5.7.3 South America Florfenicol Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Florfenicol Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Florfenicol Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Florfenicol Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Florfenicol Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Florfenicol Sales by Type (2021-2032)
- 6.1.1 Global Florfenicol Sales by Type (2021-2032) & (Ton)
- 6.1.2 Global Florfenicol Sales Market Share by Type (2021-2032)
- 6.2 Global Florfenicol Revenue by Type (2021-2032)
- 6.2.1 Global Florfenicol Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Florfenicol Revenue Market Share by Type (2021-2032)
- 6.3 Global Florfenicol Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Florfenicol Sales by Application (2021-2032)
- 7.1.1 Global Florfenicol Sales by Application (2021-2032) & (Ton)
- 7.1.2 Global Florfenicol Sales Market Share by Application (2021-2032)
- 7.2 Global Florfenicol Revenue by Application (2021-2032)
- 7.2.1 Global Florfenicol Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Florfenicol Revenue Market Share by Application (2021-2032)
- 7.3 Global Florfenicol Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Florfenicol Value Chain Analysis
- 8.1.1 Florfenicol Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Florfenicol Production Mode & Process
- 8.2 Florfenicol Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Florfenicol Distributors
- 8.2.3 Florfenicol Customers
9 Global Florfenicol Analyzing Market Dynamics
- 9.1 Florfenicol Industry Trends
- 9.2 Florfenicol Industry Drivers
- 9.3 Florfenicol Industry Opportunities and Challenges
- 9.4 Florfenicol Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst